Skip to main content
Article
Abstract B24: De novo and acquired resistance to first-line standard therapy in colorectal cancer: from cell lines to metastatic tumors
Clinical Cancer Research (2012)
  • Raquel Aloyz, Jewish General Hospital
  • Caroline Rousseau, Jewish General Hospital
  • Zuanel Diaz, Jewish General Hospital
  • Adriana Aguilar-Mahecha, Jewish General Hospital
  • Mark Basik, Jewish General Hospital
  • Luc Bélanger, Jewish General Hospital
  • Marguerite Buchanan, Jewish General Hospital
  • Errol Camlioglu, Jewish General Hospital
  • Andre Constantin, Jewish General Hospital
  • Naciba Benlimame, Jewish General Hospital
  • Suzan McNamara, Jewish General Hospital
  • Michèle Orain, Jewish General Hospital
  • Ewa Przybytkowski, Jewish General Hospital
  • Alan Spatz, Jewish General Hospital
  • Bernard Têtu, Jewish General Hospital
  • Lawrence Panasci, Jewish General Hospital
  • Gerald Batist, Jewish General Hospital
  • Michel Lebel, Jewish General Hospital
  • Jean-Yves Masson, Jewish General Hospital
  • David Davidson, Jewish General Hospital
  • Eric R. Paquet, Jewish General Hospital
  • Haji Hassan Houssein, Jewish General Hospital
  • Annie Maltais, Jewish General Hospital
  • Therese Gagnon-Kugler, Jewish General Hospital
Publication Date
May 15, 2012
DOI
10.1158/1078-0432.MECHRES-B24
Citation Information
Raquel Aloyz, Caroline Rousseau, Zuanel Diaz, Adriana Aguilar-Mahecha, et al.. "Abstract B24: De novo and acquired resistance to first-line standard therapy in colorectal cancer: from cell lines to metastatic tumors" Clinical Cancer Research Vol. 18 (2012)
Available at: http://works.bepress.com/zuanel-diaz/22/